14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Monday, 6th May 2024 ANVS stock ended at $5.39. This is 4.05% more than the trading day before Friday, 3rd May 2024. During the day the stock fluctuated 9.72% from a day low at $5.25 to a day high of $5.76.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Annovis Bio, Inc. prices

Date Open High Low Close Volume
May 06, 2024 $5.30 $5.76 $5.25 $5.39 391 543
May 03, 2024 $5.47 $5.73 $4.86 $5.18 606 309
May 02, 2024 $6.20 $6.20 $5.45 $5.45 666 843
May 01, 2024 $5.46 $6.31 $5.46 $6.11 1 026 843
Apr 30, 2024 $6.89 $6.89 $5.37 $5.57 2 153 019
Apr 29, 2024 $18.00 $20.00 $5.23 $7.28 9 522 782
Apr 26, 2024 $13.71 $18.20 $13.71 $18.01 1 046 474
Apr 25, 2024 $12.55 $13.64 $12.55 $13.60 329 651
Apr 24, 2024 $11.99 $13.65 $11.99 $12.74 439 324
Apr 23, 2024 $11.57 $12.34 $11.44 $11.88 226 191
Apr 22, 2024 $10.17 $11.74 $10.10 $11.49 319 424
Apr 19, 2024 $9.85 $10.18 $9.62 $10.06 224 079
Apr 18, 2024 $9.11 $9.88 $9.04 $9.85 239 899
Apr 17, 2024 $10.00 $10.32 $8.86 $8.99 275 761
Apr 16, 2024 $11.00 $11.12 $9.60 $10.08 191 768
Apr 15, 2024 $11.68 $11.99 $10.86 $11.09 153 531
Apr 12, 2024 $12.18 $12.20 $11.59 $11.63 132 164
Apr 11, 2024 $11.90 $12.33 $11.80 $12.20 141 571
Apr 10, 2024 $11.09 $11.80 $10.86 $11.75 97 117
Apr 09, 2024 $11.48 $12.15 $11.26 $11.49 140 161
Apr 08, 2024 $10.97 $11.68 $10.91 $11.46 154 743
Apr 05, 2024 $11.19 $11.59 $10.85 $11.10 185 895
Apr 04, 2024 $11.22 $11.47 $10.87 $11.04 184 986
Apr 03, 2024 $11.25 $11.59 $11.14 $11.29 116 993
Apr 02, 2024 $12.24 $12.32 $11.07 $11.18 200 117
Click to get the best stock tips daily for free!

About Annovis Bio, Inc.

Annovis Bio. Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for prote... ANVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT